These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31835010)

  • 21. Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017.
    Wingate H; Sizemore L; Black J; Heth Z; Talley P; Patrick SW; Wester C
    Public Health Rep; 2022; 137(5):860-866. PubMed ID: 34404285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Surveillance and Investigations in Workplaces - Seattle & King County, Washington, June 15-November 15, 2020.
    Bonwitt J; Deya RW; Currie DW; Lipton B; Huntington-Frazier M; Sanford SJ; Pallickaparambil AJ; Hood J; Rao AK; Kelly-Reif K; Luckhaupt SE; Pogosjans S; Lindquist S; Duchin J; Kawakami V; ;
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(25):916-921. PubMed ID: 34166336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
    Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L
    Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
    Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
    J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.
    Chhatwal J; Chen Q; Bethea ED; Hur C; Spaulding AC; Kanwal F
    Aliment Pharmacol Ther; 2019 Jul; 50(1):66-74. PubMed ID: 31115920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of acute viral hepatitis data quality using two methodologies, 2005-2007.
    Iqbal K; Klevens RM; Jiles R
    Public Health Rep; 2012; 127(6):591-7. PubMed ID: 23115384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City.
    Guerra K; Bocour A; Moore MS; Winters A
    J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):126-129. PubMed ID: 32956285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a public health Salmonella surveillance system in King County, Washington.
    Takahashi T; Koehler J; Swenson P; Duchin J
    Am J Infect Control; 2004 Feb; 32(1):7-11. PubMed ID: 14755228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
    Brouard C; Pillonel J; Boussac M; de Lédinghen V; Rachas A; Silvain C; Lydié N; Chevaliez S; Pioche C; Durand J; Lot F; Delarocque-Astagneau E
    BMC Infect Dis; 2020 Oct; 20(1):759. PubMed ID: 33059617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Belperio PS; Chartier M; Ross DB; Alaigh P; Shulkin D
    Ann Intern Med; 2017 Oct; 167(7):499-504. PubMed ID: 28973196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis C: epidemiology, management and treatment].
    Poupon R
    Bull Acad Natl Med; 2005 Feb; 189(2):375-84; discussion 384-7. PubMed ID: 16114865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.
    Alter MJ; Kuhnert WL; Finelli L;
    MMWR Recomm Rep; 2003 Feb; 52(RR-3):1-13, 15; quiz CE1-4. PubMed ID: 12585742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.
    Tsui JI; Miller CM; Scott JD; Corcorran MA; Dombrowski JC; Glick SN
    Drug Alcohol Depend; 2019 Feb; 195():114-120. PubMed ID: 30611979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.
    Sacks-Davis R; Doyle JS; Rauch A; Beguelin C; Pedrana AE; Matthews GV; Prins M; van der Valk M; Klein MB; Saeed S; Lacombe K; Chkhartishvili N; Altice FL; Hellard ME
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25051. PubMed ID: 29633559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.